Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist with focus on gastrointestinal malignancies at the Massachusetts General Hospital (MGH) Cancer Center. Dr. Ting’s laboratory utilizes RNA-sequencing and RNA in situ hybridization technologies for pancreatic cancer theranostics. He is co-Editor-in-Chief of the journal Cancer Convergence.
Last January, the Stand Up To Cancer (ST2C) charitable program announced the “Convergence 2.0” research initiative, which awards $11M to seven highly… Read more »
